---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292923868.md"
description: "Intellia Therapeutics shares are trading lower after Wolfe Research downgraded the stock from Peer Perform to Underperform rating and announced a $9 price target."
datetime: "2026-07-16T14:40:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292923868.md)
  - [en](https://longbridge.com/en/news/292923868.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292923868.md)
generator: "portal-rs"
---

# 

Intellia Therapeutics shares are trading lower after Wolfe Research downgraded the stock from Peer Perform to Underperform rating and announced a $9 price target.

### Related Stocks

- [NTLA.US](https://longbridge.com/en/quote/NTLA.US.md)

## Related News & Research

- [Intellia Q2 2026 Earnings: Lonvo-z Moves Toward a BLA](https://longbridge.com/en/news/295103160.md)
- [Intellia Therapeutics (NASDAQ:NTLA)  Shares Down 6.4%   - Time to Sell?](https://longbridge.com/en/news/296515889.md)
- [LBL: Strong revenue and profit growth achieved despite tungsten price headwinds and mining sector softness](https://longbridge.com/en/news/296423247.md)
- [Global Supply Concerns Fuel a Rally in Sugar Prices](https://longbridge.com/en/news/296259550.md)
- [If You Invested $1000 In Twilio Stock 10 Years Ago, You Would Have This Much Today](https://longbridge.com/en/news/296658583.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**